TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
MBX

MBX Biosciences, Inc.

Healthcare · Biotechnology

57.80$ +0.4% vs. previous close Closing price · As of: Sep 29, 2026

Statements

Balance Sheet

MBX Biosciences, Inc. (MBX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 436 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet MBX
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
– 84 75 63 282 269 246 232 400 385 453 436
– 83 73 59 281 267 244 229 398 382 449 428
– 31 35 13 133 49 30 40 223 75 45 54
– 81 70 55 277 262 241 225 392 374 440 419
– 0.2 0.2 0.2 0.9 0.7 1.4 0.8 1.5 2.1 3.2 3.0
– – 0.0 – – – – – – – – –
– 157 6.0 161 11 11 11 12 13 16 15 26
– 3.9 5.7 8.2 11 11 10 12 12 15 15 24
– 0.2 0.2 0.2 0.2 0.2 0.1 0.1 0.2 0.2 0.2 0.6
– 1.4 3.2 3.2 5.0 5.3 4.2 5.8 3.8 3.0 7.0 4.4
– -72 69 -98 271 257 235 219 388 369 438 410
– -76 -88 -104 -122 -138 -161 -181 -202 -224 -248 -285
32 32 33 33 33 33 33 33 34 37 47 48

Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?